ID
31804
Beschrijving
Study Comparing Bevacizumab + Temsirolimus vs. Bevacizumab + Interferon-Alfa In Advanced Renal Cell Carcinoma Subjects; ODM derived from: https://clinicaltrials.gov/show/NCT00631371
Link
https://clinicaltrials.gov/show/NCT00631371
Trefwoorden
Versies (1)
- 29-09-18 29-09-18 -
Houder van rechten
See clinicaltrials.gov
Geüploaded op
29 september 2018
DOI
Voor een aanvraag inloggen.
Licentie
Creative Commons BY 4.0
Model Commentaren :
Hier kunt u commentaar leveren op het model. U kunt de tekstballonnen bij de itemgroepen en items gebruiken om er specifiek commentaar op te geven.
Itemgroep Commentaren voor :
Item Commentaren voor :
U moet ingelogd zijn om formulieren te downloaden. AUB inloggen of schrijf u gratis in.
Eligibility Renal Cell Carcinoma NCT00631371
Eligibility Renal Cell Carcinoma NCT00631371
- StudyEvent: Eligibility
Beschrijving
Exclusion Criteria
Alias
- UMLS CUI
- C0680251
Beschrijving
Systemic therapy Renal Cell Carcinoma
Datatype
boolean
Alias
- UMLS CUI [1,1]
- C1515119
- UMLS CUI [1,2]
- C0007134
Beschrijving
CNS metastases
Datatype
boolean
Alias
- UMLS CUI [1]
- C0686377
Beschrijving
Cardiovascular Disease
Datatype
boolean
Alias
- UMLS CUI [1]
- C0007222
Beschrijving
Pregnancy | Breast Feeding
Datatype
boolean
Alias
- UMLS CUI [1]
- C0032961
- UMLS CUI [2]
- C0006147
Beschrijving
Criteria Additional
Datatype
boolean
Alias
- UMLS CUI [1,1]
- C0243161
- UMLS CUI [1,2]
- C1524062
Similar models
Eligibility Renal Cell Carcinoma NCT00631371
- StudyEvent: Eligibility
C0205179 (UMLS CUI [1,2])
C1705248 (UMLS CUI [1,2])
C0205164 (UMLS CUI [1,3])
C1265611 (UMLS CUI [1,2])
C0007134 (UMLS CUI [1,2])
C0006147 (UMLS CUI [2])
C1524062 (UMLS CUI [1,2])